INTerpath-001 Trial: Personalized mRNA Cancer Vaccine in High-Risk Melanoma
20 Posts Not to Miss from ESMO Congress 2026: Day 2
DeLLphi-305: Tarlatamab–Durvalumab Redefines First-Line Maintenance in Extensive-Stage SCLC
Paris Hilton and Kathy Hilton Host Pink Fundraiser for Breast Cancer Research in Beverly Hills
Lacy Hubbard: Rwanda Reaches a Major Milestone in HPV Screening With Mission 2027
Amol Akhade and Mohana Murali Kolluri at COGC 2026: The Cancer Care Gap in Asia-Pacific
London Global Cancer Week 2026 Speakers
Inside ESMO 2026 with Amol Akhade
OncoDaily GU is OncoDaily’s dedicated platform for genitourinary cancers, highlighting important advances across the GU oncology landscape. The platform covers prostate, bladder, kidney (renal cell), testicular, penile, and other genitourinary malignancies. From clinical trial results and ongoing research to FDA and EMA approvals, updated treatment guidelines, emerging therapies, biomarker discoveries, precision medicine, and major conference data, OncoDaily GU keeps readers informed about developments shaping the field. The platform also features expert interviews and perspectives from leading specialists in GU oncology.
